Guillem Estivill
guillemxtivill.bsky.social
Guillem Estivill
@guillemxtivill.bsky.social
PhD student at @IMPVienna - @evomet_itn | Cancer immunology, metastasis and therapy resistance 🔬🐁
Reposted by Guillem Estivill
Interested in inflammatory monocytes - check this outstanding piece from @obenaufa.bsky.social and team! Great study! www.nature.com/articles/s41...
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity - Nature
Inflammatory monocytes are identified as important players in T cell restimulation in the tumour microenvironment.
www.nature.com
November 27, 2024 at 6:50 PM
Reposted by Guillem Estivill
Imagine your body as a coral reef where cancer causes pollution, but scientists found a way to remedy it.

@obenaufa.bsky.social @guillemxtivill.bsky.social @impvienna.bsky.social @natureportfolio.bsky.social

t.co/tySfh9MXSq
#ImmunoSky 🧪
December 1, 2024 at 7:08 PM
Reposted by Guillem Estivill
Another masterpiece from our friends in the Obenauf lab, deciphering an entire cascade that enables cancer cells to evade immunity & discovering a key role of monocytes in T-cell activation! Huge congrats to @obenaufa.bsky.social, @aelewaut.bsky.social, @guillemxtivill.bsky.social & all co-authors!
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 6:36 PM
Reposted by Guillem Estivill
New fundamental insights into the battle between immune cells & tumor cells: Anna @obenaufa.bsky.social's lab @impvienna.bsky.social discovered that T cells get stimulated in tumors by inflammatory monocytes, an activity blocked by oncogenic signalling through counter-regulation of PGE2 and IFN-I.
November 28, 2024 at 4:22 PM
Reposted by Guillem Estivill
Dendritic cells maintain the CAR T cell pool in irradiated tumors
www.biorxiv.org/content/10.1...
November 25, 2024 at 4:43 PM
Reposted by Guillem Estivill
Inflammatory monocytes can restimulate T cells in tumors, and cancer cell-induced disruption of this process can lead to tumor immune evasion. Details 👇 in the wonderful 🧵 by @obenaufa.bsky.social and the paper published today @Nature. What a privilege it has been to be part of this amazing team!
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 8:24 PM
Reposted by Guillem Estivill
🚨very elegant study alert 🚨
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 9:32 PM
Reposted by Guillem Estivill
Congratulations #ObenaufLab on this amazing study of how MAPK-induced PGE2 secretion induces tumor immunosuppression. Impressive work!
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 9:55 PM
Reposted by Guillem Estivill
🧪Cross-Dressing intratumoral monocytes fulfill the job of cDC1s in supporting tumor-infiltrating CD8 T cells in their anti-cancer functions. Great to have contributed some 🔬&🧫 to this tour de force study by @obenaufa.bsky.social
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 9:43 PM
Reposted by Guillem Estivill
#InterferonPower! Elewaut, @obenaufa.bsky.social &co show @ Nature that inflammatory monocytes can acquire MHC-class I from tumor cells & locally activate CD8 T cells, given that the capacity of the tumor to shut down type I #IFNs & upreg PGE2 is reverted! www.nature.com/articles/s41...
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity - Nature
Inflammatory monocytes are identified as important players in T cell restimulation in the tumour microenvironment.
www.nature.com
November 27, 2024 at 5:38 PM
Reposted by Guillem Estivill
new out in Nature www.nature.com/articles/s41... Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity - Nature
Inflammatory monocytes are identified as important players in T cell restimulation in the tumour microenvironment.
www.nature.com
November 28, 2024 at 9:01 AM
Reposted by Guillem Estivill
Cancer cells blunt monocyte IFN while increasing PGE2 to inhibit T cell immunity @obenaufa.bsky.social @aelewaut.bsky.social @guillemxtivill.bsky.social
www.nature.com/articles/s41...
November 28, 2024 at 12:26 PM
Reposted by Guillem Estivill
November 27, 2024 at 10:17 PM
Reposted by Guillem Estivill
Super excited to see this out! @aelewaut.bsky.social taught me everything I know about “real” cancer immunotherapy research from injecting mice to flow cytometry 🐁Congratulations @guillemxtivill.bsky.social @obenaufa.bsky.social and the Obenauf Lab!
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 6:42 PM
Reposted by Guillem Estivill
That was a really fun and fruitful collaboration, we learned so much from each other! Thanks again ☺️
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 6:32 PM
Reposted by Guillem Estivill
Extremely excited to see my PhD work in the @obenaufa.bsky.social published today in @natureportfolio.bsky.social 🤩. A big thank you to everyone who contributed, special thank you to my partner in crime @guillemxtivill.bsky.social - it was a lot of fun to work on this together! 🥳
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 7:53 PM
Reposted by Guillem Estivill
#Immunotherapy has transformed #cancer treatment, but some cancers evade immune defenses, causing resistance.

@obenaufa.bsky.social's lab has discovered how inflammatory monocytes—a type of immune cell—can reactivate cancer-killing T cells within tumors.

Read more: imp.ac.at/news/article...
November 27, 2024 at 4:17 PM